Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study
Saqmolo
The Effects ofComplementary Feeding of Eggs on Infant Developmentand Growth in Guatemala: The Saqmolo Study
1 other identifier
interventional
1,200
1 country
1
Brief Summary
The specific aims of this study are: In a randomized controlled trial, the investigators will evaluate the impact of daily egg consumption during the complementary feeding period in addition to the local standard of nutrition care (i.e., intervention group), compared to the local standard of nutrition care alone (i.e., control group) on the following outcomes, in infants that are \~6-month old at baseline:
- 1.Child development, as measured by global development scores (primary outcome)
- 2.Growth, as measured by anthropometrics (secondary outcome)
- 3.Diet quality, as measured by the World Health Organization infant and young child feeding indicators (secondary outcome)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2020
CompletedFirst Posted
Study publicly available on registry
March 20, 2020
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedMarch 13, 2026
March 1, 2026
2.5 years
March 16, 2020
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Caregiver Reported Child Development Instruments (CREDI)
The long form CREDI uses caregiver report and captures five domains: motor, language, cognition, social-emotional, and mental health. The CREDI is designed specifically to measure normal development within populations and has been tested in high, middle and low income countries The CREDI included a Guatemalan sample in the validation
6 months
Guide for Monitoring Child Development (GMCD)
The GMCD has been used in low- and middle-income countries in children ages 0-24 months and focuses on seven areas: expressive language, receptive language, fine motor, gross motor, relating, play, and self-help.
6 months
Secondary Outcomes (5)
changes in infant hemoglobin
6 months
weight-for-age
6 months
length-for-age
6 months
Head circumference
6 months
Infant diet quality
6 months
Study Arms (2)
Control
ACTIVE COMPARATORThe standard of nutrition care in Guatemala includes the following clinical care, as determined to be necessary by the MHA medical and nutrition teams: frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.
Intervention
EXPERIMENTALThe intervention group will receive an intervention to promote daily egg consumption for a six month period, in addition to the local standard of nutrition care. Specifically, intervention group participants will be provided with enough eggs for the infant to consume one egg, daily, for six months, and also with education on preparation and consumption of eggs.
Interventions
Eggs will be secured locally and delivered to families weekly.
frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.
Eligibility Criteria
You may qualify if:
- Infants who are 6.0-9.0 months of age at baseline
- At least one caregiver willing to provide oral informed consent
- Planned residence in the study area for approximately the next 18 months
- Singleton birth
You may not qualify if:
- Infants with moderate to severe acute malnutrition (weight-for-length z-score \< -2)
- Infants with severe anemia (Hgb \<7 g/dL per WHO guidelines, with adjustments for altitude as necessary)
- Infants with a chronic medical condition that affects growth (e.g., congenital heart disease, genetic condition) as determined by the MHA staff physician
- Infants whose caregivers have cognitive or other impairments that prevent them from being able to provide informed consent or to reliably provide information required for the developmental assessments
- Infants with a known egg allergy
- Infants with recalcitrant, moderate-to-severe atopic dermatitis
- Infants with a history of anaphylaxis or serious allergic reaction to any substance requiring emergency medical care
- Concurrent participation in any other clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Academy of Nutrition and Dieteticslead
- Wuqu' Kawoq, Maya Health Alliancecollaborator
- Think Healthy Group, Inc.collaborator
Study Sites (1)
Wuqu' Kawoq/Maya Health Alliance
Tecpán Guatemala, Departamento de Chimaltenango, Guatemala
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2020
First Posted
March 20, 2020
Study Start
April 1, 2021
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share